Skip to main content

Peer Review reports

From: Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis

Original Submission
10 Jan 2023 Submitted Original manuscript
4 Feb 2023 Reviewed Reviewer Report
6 Feb 2023 Reviewed Reviewer Report
16 Feb 2023 Reviewed Reviewer Report
1 Mar 2023 Reviewed Reviewer Report
5 Mar 2023 Reviewed Reviewer Report
12 Apr 2023 Author responded Author comments - Gang Zhang
Resubmission - Version 2
12 Apr 2023 Submitted Manuscript version 2
26 Apr 2023 Reviewed Reviewer Report
27 Apr 2023 Reviewed Reviewer Report
6 May 2023 Reviewed Reviewer Report
20 Jun 2023 Author responded Author comments - Gang Zhang
Resubmission - Version 3
20 Jun 2023 Submitted Manuscript version 3
23 Jul 2023 Reviewed Reviewer Report
11 Oct 2023 Author responded Author comments - Gang Zhang
Resubmission - Version 4
11 Oct 2023 Submitted Manuscript version 4
17 Oct 2023 Author responded Author comments - Gang Zhang
Resubmission - Version 5
17 Oct 2023 Submitted Manuscript version 5
Publishing
20 Oct 2023 Editorially accepted
3 Nov 2023 Article published 10.1186/s12885-023-11553-3

You can find further information about peer review here.

Back to article page